Wnt Signaling in Aging Discs Drives Immune Inflammation Behind Chronic Back Pain
Loss of β-catenin in disc cells slashes immune recruitment by up to 79%, revealing a Wnt-driven mechanism for age-related chronic low back pain.
Summary
Chronic low back pain becomes far more common with age, partly because aging intervertebral discs accumulate immune cells that drive inflammation. This mouse study found that β-catenin — the key signaling molecule in the Wnt pathway — plays a surprising pro-inflammatory role in disc cells. When researchers deleted β-catenin in disc cells to mimic aged tissue, the discs produced far less of a key immune-recruiting chemical (MCP-1/CCL2), and myeloid immune cells were dramatically less abundant, both at rest and after disc injury. Using advanced PET/CT imaging to track immune cells in living mice, the team showed that Wnt loss reduced immune cell burden by 79% in uninjured discs and cut injury-triggered recruitment by nearly half. The findings suggest that paradoxically, the very decline in Wnt signaling seen in aging discs may actually limit some inflammatory cascades, reshaping how scientists should think about disc degeneration and pain.
Detailed Summary
Chronic low back pain is one of the most prevalent and debilitating conditions associated with aging, yet its molecular drivers remain incompletely understood. Intervertebral disc (IVD) degeneration is a central contributor, and mounting evidence points to excessive immune cell infiltration as a key amplifier of pain and tissue destruction. This study from Mount Sinai investigated how age-related loss of Wnt signaling in disc cells shapes the inflammatory environment of the disc.
The Wnt pathway — specifically its transcriptional co-factor β-catenin — is known to decline with aging in all IVD cell types. The researchers used two genetic mouse models to delete β-catenin selectively: one targeting all IVD cells (AcanCreERT2) and one targeting nucleus pulposus cells, which lose Wnt signaling earliest in life (ShhCreERT2). Both male and female mice were studied, and PET/CT imaging was used to quantify myeloid immune cell presence in living animals.
The results were striking. Deletion of β-catenin reduced expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) by 58% in male and 79% in female IVDs. At baseline, myeloid cell burden in uninjured discs fell by 79%. After disc injury — a model of acute discogenic trauma — immune cell recruitment was attenuated by 48% in β-catenin-deficient animals. RNA sequencing confirmed that β-catenin deletion in nucleus pulposus cells broadly impaired activation of immune cell signaling pathways following injury.
These findings reframe the role of Wnt signaling in disc aging. Rather than being purely protective, active Wnt/β-catenin signaling appears to drive chemokine production and immune recruitment in disc tissue. Its decline with aging may actually reduce acute inflammatory responses, but paradoxically this may still contribute to the chronic, unresolved low-grade inflammation characteristic of aged discs.
For clinicians and researchers, this work identifies the Wnt/β-catenin–CCL2 axis as a potential therapeutic target for discogenic pain. Modulating this pathway — rather than simply boosting Wnt activity — may offer a more nuanced strategy for reducing disc inflammation. Caveats include the mouse model, abstract-only access, and the complexity of translating chemokine biology to human disc disease.
Key Findings
- β-catenin deletion slashed MCP-1/CCL2 expression by 58–79% in male and female mouse IVDs.
- Myeloid immune cell burden in uninjured discs dropped 79% when β-catenin was absent from disc cells.
- Injury-induced immune cell recruitment to the disc was cut by 48% without β-catenin signaling.
- Nucleus pulposus-specific β-catenin loss broadly impaired immune pathway activation after disc injury.
- Wnt/β-catenin signaling drives disc inflammation — its age-related decline may paradoxically alter chronic pain dynamics.
Methodology
Researchers used two conditional knockout mouse models (AcanCreERT2 and ShhCreERT2) to delete β-catenin in IVD cells, with n=5–6 per sex for gene expression analyses and n=4 IVDs per sex per group for imaging. Myeloid cell recruitment was quantified in vivo using PET/CT imaging in 5-month-old mice, and transcriptomic changes were assessed via RNA sequencing of injured IVDs.
Study Limitations
This summary is based on the abstract only, as the full paper is not open access. The study was conducted entirely in mice, and translation to human disc biology requires caution. Sex-specific differences in CCL2 reduction (58% vs. 79%) warrant further investigation to understand whether findings apply equally across biological sexes in humans.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe:
